Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANX005 in Warm Autoimmune Hemolytic Anemia (wAIHA)
NCT04691570Phase 2Completed
- Sponsor
- Annexon Biosciences
- Start
- Nov 2021
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of tanruprubart in warm autoimmune hemolytic anemia (wAIHA), sponsored by Annexon Biosciences. Started Nov 2021; status: completed.
02
Drugs
tanruprubart
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT04691570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691570.